SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001839882-23-006927
Filing Date
2023-03-16
Accepted
2023-03-16 19:42:05
Documents
1
Period of Report
2023-03-15

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP stillwell-form3_031523.html 3  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP stillwell-form3_031523.xml 3 2913
  Complete submission text file 0001839882-23-006927.txt   4452
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Issuer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TONIX PHARMACEUTICALS HOLDING CORP. 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address
Stillwell Richard Newcomb (Reporting) CIK: 0001966861 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36019 | Film No.: 23740341